Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The National AIDS Therapy Evaluation Center (NATEC) was a prominent clinical research organization based at the Academic Medical Center (AMC) in Amsterdam, specializing in the evaluation of therapies for HIV/AIDS. Founded in 1990 by Professor Joep Lange, NATEC established a national network of clinical trial sites in the Netherlands and became a key partner in international research collaborations, including the HIV Netherlands-Australia-Thailand Research Collaboration (HIV-NAT). The center provided essential infrastructure for multi-center clinical trials, including statistical analysis and data management services, and was instrumental in the early development and implementation of highly active antiretroviral therapy (HAART). Following the merger of AMC and VUmc into Amsterdam UMC, its activities have been integrated into the broader infectious disease research departments and the Amsterdam Institute for Global Health and Development (AIGHD).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AMC-NATEC.